NICE supports Theramex’s Eladynos for post-menopause osteoporosis

Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP) used to increase bone density.

Aug 11, 2024 - 04:00

NICE supports Theramex’s Eladynos for post-menopause osteoporosis

Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP) used to increase bone density.

Read the original article

Tags:

Previous Article

MSD sets sights on bispecific antibody market with Curon acqusition

Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Pharmalittle: House panel inches into fixing drug shortages; pharma could face legal action over improper patent listings

STAT+: Pharmalittle: House panel inches into fixing dru...

Sep 16, 2023

Lundbeck acquires all outstanding shares of Longboard Pharma

Lundbeck acquires all outstanding shares of Longboard P...

Dec 5, 2024

SyntheticGestalt and Enamine partner on AI drug discovery models

SyntheticGestalt and Enamine partner on AI drug discove...

Jan 13, 2024